These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 1683626

  • 1. [Complete neuroleptic withdrawal in patients with schizophrenia with intense symptoms and resistant to treatment].
    Wolf MA, Bailly L, Diener JM, Martinet JP, Peretti S, Garneau Y.
    Encephale; 1991; 17(4):255-61. PubMed ID: 1683626
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
    Langlois-Thery S, Dollfus S, Lesieur P, Petit M.
    Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
    [Abstract] [Full Text] [Related]

  • 6. Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics.
    Wistedt B, Palmstierna T.
    J Clin Psychiatry; 1983 Oct; 44(10):369-71. PubMed ID: 6643398
    [Abstract] [Full Text] [Related]

  • 7. [Clinical effects of clozapine: effect on negative symptoms].
    Llorca PM, Lançon C, Auquier P, Bougerol T.
    Encephale; 1996 Oct; 22(4):287-92. PubMed ID: 9035984
    [Abstract] [Full Text] [Related]

  • 8. Effect of maprotiline combined with conventional neuroleptics against negative symptoms of chronic schizophrenia.
    Yamagami S, Soejima K.
    Drugs Exp Clin Res; 1989 Oct; 15(4):171-6. PubMed ID: 2570687
    [Abstract] [Full Text] [Related]

  • 9. [Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal].
    Ben Hadj Ali B, Dogui M, Ben Ammou S, Lôo H.
    Encephale; 1995 Oct; 21(3):209-15. PubMed ID: 7649071
    [Abstract] [Full Text] [Related]

  • 10. [Discontinuation of antipsychotic drugs in chronic schizophrenic patients. II. Psychological and psychopathological test differences between patients with and without relapse].
    Woggon B, Bickel P, Schnyder B.
    Int Pharmacopsychiatry; 1979 Oct; 14(5):278-93. PubMed ID: 43849
    [Abstract] [Full Text] [Related]

  • 11. [Neuroleptic malignant syndrome. Case reports].
    Berardi D, Troia M, Veronesi L, Ferrari G.
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [Abstract] [Full Text] [Related]

  • 12. [New chemotherapy approaches to psychoses].
    Olié JP, Baylé FJ.
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [Abstract] [Full Text] [Related]

  • 13. Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: A preliminary study.
    Krivoy A, Weizman A, Laor L, Hellinger N, Zemishlany Z, Fischel T.
    Eur Neuropsychopharmacol; 2008 Feb; 18(2):117-21. PubMed ID: 17728110
    [Abstract] [Full Text] [Related]

  • 14. [Treatment refractory schizophrenia].
    Vanelle JM.
    Encephale; 1995 Jun; 21 Spec No 3():13-21. PubMed ID: 7628336
    [Abstract] [Full Text] [Related]

  • 15. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G, Noisette C, Legrand A, Delahousse J.
    Encephale; 1997 Jun; 23(1):10-8. PubMed ID: 9172962
    [Abstract] [Full Text] [Related]

  • 16. [Profile of the action of neuroleptics in deficit schizophrenia].
    Vanelle JM.
    Encephale; 1996 Jun; 22 Spec No 2():33-9. PubMed ID: 8767040
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
    Gaebel W, Möller HJ, Buchkremer G, Ohmann C, Riesbeck M, Wölwer W, Von Wilmsdorff M, Bottlender R, Klingberg S.
    Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342
    [Abstract] [Full Text] [Related]

  • 18. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I, Castro-Fornieles J, Deulofeu R, de la Serna E, Goti J, Salvà J, Bernardo M.
    Psychiatry Res; 2009 Jul 30; 168(2):110-8. PubMed ID: 19501918
    [Abstract] [Full Text] [Related]

  • 19. [Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial].
    Shiloh R, Weizman A, Weizer N, Dorfman-Etrog P, Munitz H.
    Harefuah; 2001 May 30; 140(5):369-73, 456. PubMed ID: 11419053
    [Abstract] [Full Text] [Related]

  • 20. Cannabidiol monotherapy for treatment-resistant schizophrenia.
    Zuardi AW, Hallak JE, Dursun SM, Morais SL, Sanches RF, Musty RE, Crippa JA.
    J Psychopharmacol; 2006 Sep 30; 20(5):683-6. PubMed ID: 16401651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.